1. bookVolumen 69 (2019): Edición 3 (September 2019)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

An overview of structurally diversified anticonvulsant agents

Publicado en línea: 26 Jun 2019
Volumen & Edición: Volumen 69 (2019) - Edición 3 (September 2019)
Páginas: 321 - 344
Aceptado: 15 Dec 2018
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

1. R. Fisher, W. Boas, W. Blume, C. Elger, P. Genton, P. Lee and J. Engel, Epileptic seizures and epilepsy: definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE), Epilepsia46 (2005) 470–472; https://doi.org/10.1111/j.0013-9580.2005.66104.x10.1111/j.0013-9580.2005.66104.xSearch in Google Scholar

2. P. A. Dekker, Epilepsy: A Manual for Medical and Clinical Officers in Africa, WHO, Geneva 2002, pp. 133.Search in Google Scholar

3. M. J. Brodie, A. T. Elder and P. Kwan, Epilepsy in later life, Lancet Neurol. 8 (2009) 1019–1030; https://doi.org/10.1016/S1474-4422(09)70240-610.1016/S1474-4422(09)70240-6Search in Google Scholar

4. E. Proulx, Y. Leshchenko, L. Kokarovtseva, V. Khokhotva, M. El-Beheiry, O. C. Snead and J. L. P. Velazquez, Functional contribution of specific brain areas to absence seizures: role of thalamic gapjunctional coupling, Eur. J. Neurosci.23 (2006) 489–496; https://doi.org/10.1111/j.1460-9568.2005.04558.x10.1111/j.1460-9568.2005.04558.x16420455Search in Google Scholar

5. S. F. Berkovic, R. A. Howell, D. A. Hay and J. L. Hopper, Epilepsies in twins: Genetics of the major epilepsy syndromes, Ann. Neurol.43 (1998) 435–445; https://doi.org/10.1002/ana.41043040510.1002/ana.4104304059546323Search in Google Scholar

6. L. A. Corey, J. M. Pellock, M. J. Kjeldsen and K. O. Nakken, Importance of genetic factors in the occurrence of epilepsy syndrome type: A twin study, Epilepsy Res.97 (2011) 103–111; https://doi.org/10.1016/j.eplepsyres.2011.07.01810.1016/j.eplepsyres.2011.07.018321584321885256Search in Google Scholar

7. M. J. Kjeldsen, L. A. Corey, M. H. Solaas, M. L. Friis, J. R. Harris, K. O. Kyvik, K. Christensen and J. M. Pellock, Genetic factors in seizures: A population-based study of 47,626 US, Norwegian and Danish twin pairs, Twin Res. Hum. Genet.8 (2005) 138–147; https://doi.org/10.1375/183242705373883610.1375/183242705373883615901477Search in Google Scholar

8. M. Li, X. Heng, R. Tao, J. Liu, L. Zhang, X. Sun, L. Wang, Q. Wu, F. Che and F. Xue, A genetic epidemiological survey of idiopathic epilepsy in the Chinese Han population, Epilepsy Res.98 (2012) 199–205; https://doi.org/10.1016/j.eplepsyres.2011.09.01310.1016/j.eplepsyres.2011.09.01321993360Search in Google Scholar

9. R. R. Nair and S. V. Thomas, Genetic liability to epilepsy in Kerala State India, Epilepsy Res.62 (2004) 163–170; https://doi.org/10.1016/j.eplepsyres.2004.08.00710.1016/j.eplepsyres.2004.08.00715579304Search in Google Scholar

10. R. Ottman, Genetic influences on risk for epilepsy, in Pediatric Epilepsy: Diagnosis and Therapy, Demos Medical Publishing, New York 2007.Search in Google Scholar

11. H. J. Li, R. P. Wan, L. J. Tang, S. J. Liu, Q. H. Zhao, M. M. Gao, Y. H. Yi, W. P. Liao, X. F. Sun and Y. S. Long, Alteration of Scn3a expression is mediated via CpG methylation and MBD2 in mouse hippo-campus during postnatal development and seizure condition, Biochim. Biophys. Acta1849 (2015) 1–9; https://doi.org/10.1016/j.bbagrm.2014.11.00410.1016/j.bbagrm.2014.11.00425459751Search in Google Scholar

12. K. Nagai, T. Natori, T. Nishino and F. Kodaira, Epigenetic dysregulation induces cell growth retardation in primary cultured glial cells, J. Biosci. Bioeng.105 (2008) 470–475; https://doi.org/10.1263/jbb.105.47010.1263/jbb.105.47018558336Search in Google Scholar

13. E. Hessen, M. I. Lossius, I. Reinvang and L. Gjerstad, Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy, Epilepsia47 (2006) 2038–2045; https://doi.org/10.1111/j.1528-1167.2006.00805.x10.1111/j.1528-1167.2006.00805.xSearch in Google Scholar

14. V. C. Terra, R. Amorim, C. Silvado, A. J. de Oliveira, C. L. Jorge, E. Faveret, P. Ragazzo and L. De Paola, Vagus nerve stimulator in patients with epilepsy: indications and recommendations for use, Arq. Neuro-Psiquiatr.71 (2013) 902–906; https://doi.org/10.1590/0004-282X2013011610.1590/0004-282X20130116Search in Google Scholar

15. P. Lisowska and B. Daly, Vagus nerve stimulation therapy (VNST) in epilepsy - implications for dental practice, Br. Dent. J.212 (2012) 69–72; https://doi.org/10.1038/sj.bdj.2012.4710.1038/sj.bdj.2012.47Search in Google Scholar

16. B. M. Uthman, Vagus nerve stimulation for seizures, Arch. Med. Res.31 (2000) 300–303; https://doi.org/10.1016/S0188-4409(00)00060-610.1016/S0188-4409(00)00060-6Search in Google Scholar

17. I. S. Cooper and A. R. M. Upton, Use of chronic cerebellar stimulation for disorders of disinhibition, Lancet311 (1978) 595–600; https://doi.org/http://doi.org/10.1016/S0140-6736(78)91038-310.1016/S0140-6736(78)91038-3Search in Google Scholar

18. I. S. Cooper, A. R. M. Upton and I. Amin, Reversibility of chronic neurologic deficits: Some effects of electrical stimulation of the thalamus and internal capsule in man, Appl. Neurophysiol. 43 (1980) 224–258; https://doi.org/10.1159/00010226310.1159/0001022636975064Search in Google Scholar

19. K. W. Baranano and A. L. Hartman, The ketogenic diet: Uses in epilepsy and other neurologic illnesses, Curr. Treat. Options Neurol. 10 (2008) 410–419.10.1007/s11940-008-0043-8289856518990309Search in Google Scholar

20. A. L. Rogovik and R. D. Goldman, Ketogenic diet for treatment of epilepsy, Can. Fam. Physician56 (2010) 540–542.Search in Google Scholar

21. M. Greener, Food for thought: the ketogenic diet for epilepsy, Prog. Neurol. Psychiatry18 (2014) 6–9; https://doi.org/10.1002/pnp.32910.1002/pnp.329Search in Google Scholar

22. M. Ne, L. Ngo, J. I. Sirven and M. R. Sperling, Ketogenic diet in adolescents and adults with epilepsy, Seizure23 (2014) 439–442; https://doi.org/10.1016/j.seizure.2014.02.01510.1016/j.seizure.2014.02.01524675110Search in Google Scholar

23. R. Hanaya and K. Arita, The new antiepileptic drugs: their neuropharmacology and clinical indications, Neurol. Med. Chir. (Tokyo) 56 (2016) 205–220; https://doi.org/10.2176/nmc.ra.2015-034410.2176/nmc.ra.2015-0344487017526935782Search in Google Scholar

24. J. A. French and D. M. Gazzola, New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety? Ther. Adv. Drug Saf.2 (2011) 141–158; https://doi.org/10.1177/204209861141112710.1177/2042098611411127Search in Google Scholar

25. G. Gatti, I. Bonomi, G. Jannuzzi and E. Perucca, The new antiepileptic drugs: Pharmacological and clinical aspects, Curr. Pharm. Design6 (2000) 839–860; https://doi.org/10.2174/138161200340024510.2174/1381612003400245Search in Google Scholar

26. A. Nicolson and J. P. Leach, Future prospects for the drug treatment of epilepsy, CNS Drugs15 (2001) 955–968; https://doi.org/10.2165/00023210-200115120-0000510.2165/00023210-200115120-00005Search in Google Scholar

27. C. T. Supuran, F. Mincione, A. Scozzafava, F. Briganti, G. Mincione and M. A. Ilies, Carbonic anhydrase inhibitors – Part 52. Metal complexes of heterocyclic sulfonamides: A new class of strong topical intraocular pressure-lowering agents in rabbits, Eur. J. Med. Chem.33 (1998) 247–254; https://doi.org/10.1016/S0223-5234(98)80059-710.1016/S0223-5234(98)80059-7Search in Google Scholar

28. M. Ilies, C. T. Supuran, A. Scozzafava, A. Casini, F. Mincione, L. Menabuoni, M. T. Caproiu, M. Maganu and M. D. Banciu, Carbonic anhydrase inhibitors. Sulfonamides incorporating furan-, thiopheneand pyrrole-carboxamido groups possess strong topical intraocular pressure lowering properties as aqueous suspensions, Bioorg. Med. Chem. 8 (2000) 2145–2155; https://doi.org/10.1016/S0968-0896(00)00143-710.1016/S0968-0896(00)00143-7Search in Google Scholar

29. A. Scozzafava, L. Menabuoni, F. Mincone, F. Briganti, G. Mincione and C. T. Supuran, Carbonic anhydrase inhibitors. Perfluoroalkyl/aryl-substituted derivatives of aromatic/heterocyclic sulfonamides as topical intraocular pressure lowering agents with prolonged duration of action, J. Med. Chem.43 (2000) 4542–4551; https://doi.org/10.1021/jm000296j10.1021/jm000296j11087579Search in Google Scholar

30. A. Casini, A. Scozzafava, F. Mincione, L. Menabuoni, M. A. Ilies and C. T. Supuran, Carbonic anhydrase inhibitors: Water soluble 4-sulfamoylphenyl-thioureas as topical intraocular pressure-lowering agents with long-lasting effects, J. Med. Chem.43 (2000) 4884–4892; https://doi.org/10.1021/jm001051+10.1021/jm001051+11123998Search in Google Scholar

31. B. Masereel, S. Rolin, F. Abbate, A. Scozzafava and C. T. Supuran, Carbonic anhydrase inhibitors: Anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties, J. Med. Chem. 45 (2002) 312–320; https://doi.org/10.1021/jm010919910.1021/jm010919911784136Search in Google Scholar

32. M. A. Ilies, B. Masereel, S. Rolin, A. Scozzafava, G. Câmpeanu, V. Cîmpeanu and C. T. Supuran, Carbonic anhydrase inhibitors: aromatic and heterocyclic sulfonamides incorporating adamantyl moieties with strong anticonvulsant activity, Bioorg. Med. Chem.12 (2004) 2717–2726; https://doi.org/10.1016/j.bmc.2004.03.00810.1016/j.bmc.2004.03.00815110853Search in Google Scholar

33. I. B. Linden, G. Gothoni, P. Kontro and S. S. Oja, Anticonvulsant activity of 2-phthalimidoethane sulphonamides: New derivatives of taurine, Neurochem. Int.5 (1983) 319–324; https://doi.org/10.1016/j.bmc.2004.03.00810.1016/j.bmc.2004.03.008Search in Google Scholar

34. O. Akgul, F. S. Kilic, K. Erol and V. Pabuccuoglu, Synthesis and anticonvulsant activity of some N-phenyl-2-phtalimidoethanesulfonamide derivatives, Arch. Pharm. (Weinheim) 340 (2007) 656–660; https://doi.org/10.1002/ardp.20070016610.1002/ardp.20070016618038376Search in Google Scholar

35. N. Siddiqui, M. F. Arshad, S. A. Khan and W. Ahsan, Sulfonamide derivatives of thiazolidin-4-ones with anticonvulsant activity against two seizure models: synthesis and pharmacological evaluation, J. Enzyme Inhib. Med. Chem.25 (2010) 485–491; https://doi.org/10.3109/1475636090328283310.3109/1475636090328283320233086Search in Google Scholar

36. Y. Hu, C. Y. Li, X. M. Wang. Y. H. Yang and H. L. Zhu, 1,3,4-Thiadiazole: Synthesis, reactions, and applications in medicinal, agricultural, and materials chemistry, Chem. Rev.114 (2014) 5572–5610; https://doi.org/10.1021/cr400131u10.1021/cr400131u24716666Search in Google Scholar

37. A. K. Jain, S. Sharma, A. Vaidya, V. Ramachandran and R. K. Agrawal, 1,3,4-Thiadiazole and its derivatives: a review on recent progress in biological activities, Chem. Biol. Drug Des.81 (2013) 557–576; https://doi.org/10.1111/cbdd.1212510.1111/cbdd.1212523452185Search in Google Scholar

38. W. Dehaen, V. A. Bakulev, E. C. Taylor and J. A. Ellman, The Chemistry of 1,2,3-thiadiazoles, in The Chemistry of Heterocyclic Compounds (Ed. E. C. Taylor), 1st ed., John Wiley & Sons, New York 2004, pp. 5–240.Search in Google Scholar

39. A. Gupta, P. Mishra, S. Kashaw, V. Jatav and J. P. Stables, Synthesis and anticonvulsant activity of some novel 3-arylamino/amino-4-aryl-5-imino-Δ2-1,2,4-thiadiazoline, Eur. J. Med. Chem.43 (2008) 749–754; https://doi.org/10.1016/j.ejmech.2007.05.00810.1016/j.ejmech.2007.05.00817624632Search in Google Scholar

40. A. Gupta, P. Mishra, S. N. Pandeya, S. K. Kashaw, V. Kashaw and J. P. Stables, Synthesis and anticonvulsant activity of some substituted 1,2,4-thiadiazoles, Eur. J. Med. Chem.44 (2009) 1100–1105; https://doi.org/10.1016/j.ejmech.2008.06.01510.1016/j.ejmech.2008.06.01518672318Search in Google Scholar

41. B. Ahamad and M. Yusuf, Synthesis of aromatic aldehyde imine derivative of 2-thiobenzyl-1,3,4-thiadiazole and evaluation of their anticonvulsant activity, Indian J. Chem. B 49 (2010) 241–246.Search in Google Scholar

42. V. Jatav, P. Mishra, S. Kashaw and J. P. Stables, CNS depressant and anticonvulsant activities of some novel 3-[5-substituted1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones, Eur. J. Med. Chem.43 (2008) 1945–1954; https://doi.org/10.1016/j.ejmech.2007.12.00310.1016/j.ejmech.2007.12.00318222569Search in Google Scholar

43. A. Foroumadi, V. Sheibani, A. Sakhteman, M. Rameshk, M. Abbasi, R. Farazifard, S. A. Tabatabai and A. Shafiee, Synthesis and anticonvulsant activity of novel 2-amino-5-[4-chloro-2-(2-chlorophenoxy) phenyl]-1,3,4-thiadiazole derivatives, DARU J. Pharm. Sci.15 (2007) 89–93.Search in Google Scholar

44. X. Q. Deng, Z. Q. Dong, M. X. Song, B. Shu, S. B. Wang and Z. S. Quan, Synthesis and anticonvulsant activities of some triazolothiadiazole derivatives, Arch. Pharm. (Weinheim) 345 (2012) 565–573; https://doi.org/10.1002/ardp.20110032610.1002/ardp.20110032622532235Search in Google Scholar

45. H. Rajak, C. K. Behera, R. S. Pawar, P. K. Singour and M. D. Kharya, Synthesis and anticonvulsant evaluation of some novel 2,5-disubstituted 1,3,4-thiadiazoles: pharmacophore model studies, Acta Pol. Pharm.67 (2010) 503–510.Search in Google Scholar

46. H. Rajak, B. S. Thakur, P. Kumar, P. Parmar, P. C. Sharma, R. Veerasamy and M. D. Kharya, Synthesis and antiepileptic activity of some novel semicarbazones containing 1,3,4-thiadiazole and quinazoline ring, Acta Pol. Pharm.69 (2012) 253–261.Search in Google Scholar

47. N. Siddiqui, A. Rana, S. A. Khan, S. E. Haque, M. F. Arshad, S. Ahmed and W. Ahsan, Synthesis and preliminary screening of benzothiazol-2-yl-thiadiazole derivatives for anticonvulsant activity, Acta Pharm.59 (2009) 441–451; https://doi.org/10.2478/v10007-009-0031-x10.2478/v10007-009-0031-x19919933Search in Google Scholar

48. M. S. Yar and M. W. Akhter, Synthesis and anticonvulsant activity of substituted oxadiazole and thiadiazole derivatives, Acta Pol. Pharm.66 (2009) 393–397.Search in Google Scholar

49. K. P. Harish, K. N. Mohana and L. Mallesha, Synthesis of pyrazine substituted 1,3,4-thiadiazole derivatives and their anticonvulsant activity, Org. Chem. Int.2013 (2013) Article ID 631723 (8 pages); https://doi.org/10.1155/2013/63172310.1155/2013/631723Search in Google Scholar

50. A. H. Al Rohaimi, Neuropharmacological and toxicity study of newly prepared N-[5-(3-chloro-4-fluorophenyl)-1,3,4-thiadiazol-2-yl]-2-substituted acetamides, Acta Pol. Pharm.72 (2015) 1315–1320.Search in Google Scholar

51. J. R. Dimmock, S. C. Vashistha and J. P. Stable, Anticonvulsant properties of various acetylhydrazones, oxymoylhydrazones, and semicarbazones derived from aromatic and unsaturated carbonyl compounds, Eur. J. Med. Chem.35 (2000) 241–248; https://doi.org/10.1016/S0223-5234(00)00123-910.1016/S0223-5234(00)00123-9Search in Google Scholar

52. J. R. Dimmock, S. C. Vashistha and J. P. Stable, Ureylene anticonvulsants and related compounds, Pharmazie55 (2000) 490–494.Search in Google Scholar

53. S. N. Pandeya, H. Manjula and J. P. Stables, Design of semicarbazones and their bio-isosteric analogues as potential anticonvulsants, Pharmazie56 (2001) 121–124.Search in Google Scholar

54. S. N. Pandeya, I. Ponnilavarasan, A. Pandey, R. Lakhan and J. P. Stables, Evaluation of p-nitrophenyl substituted semicarbazones for anticonvulsant properties, Pharmazie54 (1999) 923–925.Search in Google Scholar

55. J. R. Dimmock, R. N. Puthucode, J. Tuchek, J. B. Baker, C. N. Hinko, C. L. Steinmiller and J. P. Stable, Anticonvulsant activity of 4-(4’-fluorophenoxy)benzaldehyde semicabazone, Drug. Dev. Res.46 (1999) 112–125; https://doi.org/10.1002/(SICI)1098-2299(199902)46:2<112::AID-DDR4>3.0.CO;2-N10.1002/(SICI)1098-2299(199902)46:2<112::AID-DDR4>3.0.CO;2-NSearch in Google Scholar

56. O. Alam, P. Mallick, S. P. Verma, S. J. Gilani, S. A. Khan, N. Siddiqui and W. Ahsan, Synthesis, anticonvulsant and toxicity screening of newer pyrimidine semicarbazone derivatives, Eur. J. Med. Chem.45 (2010) 2467–2472; https://doi.org/10.1016/j.ejmech.2010.02.03110.1016/j.ejmech.2010.02.031Search in Google Scholar

57. P. Yogeeswari, D. Sriram, S. Mehta, D. Nigam, M. M. Kumar, S. Murugesan and J. P. Stables, Anticonvulsant and neurotoxicity evaluation of some 6-substituted benzothiazolyl-2-thiosemicarbazones, I. L. Farmaco60 (2005) 1–5; https://doi.org/10.1016/j.farmac.2004.09.00110.1016/j.farmac.2004.09.001Search in Google Scholar

58. P. Yogeeswari, D. Sriram, V. Saraswat, J. V. Ragavendran, M. M. Kumar, S. Murugesan, R. Thirumurugan and J. P. Stables, Synthesis and anticonvulsant and neurotoxicity evaluation of N4-phthalimido phenyl (thio) semicarbazides, Eur. J. Pharm. Sci.20 (2003) 341–346; https://doi.org/10.1016/j.ejps.2003.08.00210.1016/j.ejps.2003.08.002Search in Google Scholar

59. U. Çalış, E. Septioğlu and M. D. Aytemir, Synthesis and anticonvulsant evaluation of some novel (thio) semicarbazone derivatives of arylalkylimidazole, Arzneimittelforschung61 (2011) 327–334; https://doi.org/10.1055/s-0031-129620610.1055/s-0031-1296206Search in Google Scholar

60. F. Azam, I. A. Alkskas, S. L. Khokra and O. Prakash, Synthesis of some novel N4-(naphtha[1,2-d]thiazol-2-yl)semicarbazone as potential anticonvulsants, Eur. J. Med. Chem.44 (2009) 203–209; https://doi.org/10.1016/j.ejmech.2008.02.00710.1016/j.ejmech.2008.02.007Search in Google Scholar

61. E. D. Ilieva, N. I. Petkova and R. D. Nikolova, A new and efficient method for the synthesis of 3,4-di-substituted pyrrolidine-2,5-diones, Molecules17 (2012) 4936–4949; https://doi.org/10.3390/molecules1705493610.3390/molecules17054936Search in Google Scholar

62. J. Obniska and K. Kamiński, Synthesis and anticonvulsant properties of new N-phenylamino derivatives of 2-azaspiro[4.4]nonane, 2-azaspiro[4.5]decane-1,3-dione and 3 cyclohexyl-pyrrolidine-2,5-dione. Part IV, Acta Pol. Pharm.63 (2006) 101–108.Search in Google Scholar

63. J. Obniska and K. Kamiński, Lipophilicity characterization of new N-phenylamino-azaspiranes as potential anticonvulsant agents, Biomed. Chromatogr. 20 (2006) 1185–1191; https://doi.org/10.1002/bmc.68210.1002/bmc.682Search in Google Scholar

64. J. Obniska, R. Lesyk, D. Atamanyuk and K. Kamiński, Synthesis and anticonvulsant activity of a series of N-substituted bicyclo[2,2,1]hept-5-ene-2,3-dicarboximides, Acta Pol. Pharm.62 (2005) 213–219.Search in Google Scholar

65. J. Obniska, S. Jurczyk, A. Zejc, K. Kamiński, E. Tatarczynska and K. Stachowicz, Anticonvulsant properties of N-(4-methylpiperazin-1-yl)- and N-[3-(4-methylpiperazin-1-yl)propyl] derivatives of 3-aryl and 3-spirocycloalkyl-pyrrolidine-2,5-dione, Pharmacol. Rep.57 (2005) 170–175.Search in Google Scholar

66. K. Kamiński and J. Obniska, Design, synthesis, and anticonvulsant activity of N-phenylamino derivatives of 3,3-dialkyl-pyrrolidine-2,5-diones and hexahydro-isoindole-1,3-diones, Bioorg. Med. Chem.16 (2008) 4921–4931; https://doi.org/10.1016/j.bmc.2008.03.03710.1016/j.bmc.2008.03.037Search in Google Scholar

67. J. Obniska, K. Kamiński, D. Skrzynska and J. Pichor, Synthesis and anticonvulsant activity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 3-phenyl-pyrrolidine-2,5-dione, Eur. J. Med. Chem.44 (2009) 2224–2233; https://doi.org/10.1016/j.ejmech.2008.05.02010.1016/j.ejmech.2008.05.02018603334Search in Google Scholar

68. J. Obniska, M. Kopytko, A. Zagórska, I. Chlebek and K. Kamiński, Synthesis and anticonvulsant properties of new Mannich bases derived from 3-aryl-pyrrolidine-2,5-diones. Part 1, Arch. Pharm. (Weinheim) 343 (2010) 333–341; https://doi.org/10.1002/ardp.20090025010.1002/ardp.20090025020379970Search in Google Scholar

69. K. Kamiński, S. Rzepka and J. Obniska, Synthesis and anticonvulsant activity of new 1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-diones, Bioorg. Med. Chem. Lett.21 (2011) 5800–803; https://doi.org/10.1016/j.bmcl.2011.07.11810.1016/j.bmcl.2011.07.11821875804Search in Google Scholar

70. J. Obniska, I. Chlebek and K. Kamiński, Synthesis and anticonvulsant properties of new Mannich bases derived from 3,3-disubstituted pyrrolidine-2,5-diones, Part IV, Arch. Pharm. (Weinheim) 345 (2012) 713–722; https://doi.org/10.1002/ardp.20120009210.1002/ardp.20120009222674811Search in Google Scholar

71. K. Kamiński, J. Obniska, I. Chlebek, B. Wiklik and S. Rzepka, Design, synthesis and anticonvulsant properties of new N-Mannich bases derived from 3-phenylpyrrolidine-2,5-diones, Bioorg. Med. Chem. Lett.21 (2013) 6821–6830; https://doi.org/10.1016/j.bmc.2013.07.02910.1016/j.bmc.2013.07.02923993970Search in Google Scholar

72. J. Obniska, I. Chlebek, K. Kamiński and J. Karolak-Wojciechowska, Synthesis and anticonvulsant properties of new N-Mannich bases derived from 3, 3-diphenyl- and 3-ethyl-3-methyl-pyrrolidine-2,5-diones, Part III, Arch. Pharm. (Weinheim) 346 (2013) 71–82; https://doi.org/10.1002/ardp.20120026510.1002/ardp.20120026523180594Search in Google Scholar

73. K. Kamiński, B. Wiklik and J. Obniska, Synthesis, anticonvulsant properties, and SAR analysis of differently substituted pyrrolidine-2,5-diones and piperidine-2,6-diones, Arch. Pharm. (Weinheim) 347 (2014) 840–852; https://doi.org/10.1002/ardp.20140017910.1002/ardp.20140017925196991Search in Google Scholar

74. S. Rybka, J. Obniska, A. Rapacz, B. Filipek and K. Kamiński, Synthesis, physicochemical, and anticonvulsant properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and its 3-methyl analog, Arch. Pharm. (Weinheim) 347 (2014) 768–776; https://doi.org/10.1002/ardp.20140015210.1002/ardp.20140015225139813Search in Google Scholar

75. J. Obniska, A. Rapacz, S. Rybka, B. Powroznik, E. Pekala, B. Filipek, P. Zmudzki and K. Kamiński, Design, synthesis and biological activity of new amides derived from 3-methyl-3-phenyl-2, 5-dioxopyrrolidin-1-yl-acetic acid, Eur. J. Med. Chem.102 (2015) 14–25; https://doi.org/10.1016/j.ejmech.2015.07.01710.1016/j.ejmech.2015.07.01726241874Search in Google Scholar

76. K. Kamiński, M. Zagaja, A. Rapacz, J. J. Tuszczki, M. Andres-Mach, M. Abram and J. Obniska, New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1-[1-oxo-1-(4-phenylpiperazin-1-yl) propan-2-yl]pyrrolidine-2,5-diones, Bioorg. Med. Chem.24 (2016) 606–618; https://doi.org/10.1016/j.bmc.2015.12.02710.1016/j.bmc.2015.12.02726746343Search in Google Scholar

77. A. Rapacz, S. Rybka, J. Obniska, K. Sałat, B. Powroźnik, E. Pękala and B. Filipek, Evaluation of anticonvulsant and antinociceptive properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and 3-methylpyrrolidine-2,5-dione, Naunyn-Schmiedeberg Arch. Pharmacol.389 (2016) 339–348; https://doi.org/10.1007/s00210-015-1194-210.1007/s00210-015-1194-2474964226650502Search in Google Scholar

78. S. Rybka, J. Obniska, A. Rapacz, B. Filipek and P. Zmudzki, Synthesis and anticonvulsant activity of new N-Mannich bases derived from benzhydryl- and isopropyl-pyrrolidine-2,5-dione, J. Enzyme Inhib. Med. Chem.31 (2016) 1038–1047; https://doi.org/10.3109/14756366.2015.108884210.3109/14756366.2015.108884226406340Search in Google Scholar

79. S. Rybka, J. Obniska, A. Rapacz, B. Filipek and P. Zmudzki, Synthesis and evaluation of anticonvulsant properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and its 3-methyl-, 3-isopropyl, and 3-benzhydryl analogs, Bioorg. Med. Chem. Lett.27 (2017) 1412–1415; https://doi.org/10.1016/j.bmcl.2017.02.00210.1016/j.bmcl.2017.02.00228202327Search in Google Scholar

80. F. Schiaffella, A. Macchiarulo, L. Milanese, A. Vecchiarelli and R. Fringuelli, Novel ketoconazole analogues based on the replacement of 2,4-dichlorophenyl group with 1,4-benzothiazine moiety: Design, synthesis, and microbiological evaluation, Bioorg. Med. Chem.14 (2006) 5196–5203; https://doi.org/10.1016/j.bmc.2006.04.00410.1016/j.bmc.2006.04.00416650767Search in Google Scholar

81. L. Navidpour, H. Shadnia, H. Shafaroodi, M. Amini, A. R. Dehpour and A. Shafiee, Design, synthesis, and biological evaluation of substituted 2-alkylthio-1,5-diarylimidazoles as selective COX-2 inhibitors, Bioorg. Med. Chem.15 (2007) 1976–1982; https://doi.org/10.1016/j.bmc.2006.12.04110.1016/j.bmc.2006.12.04117258905Search in Google Scholar

82. J. C. Thenmozhiyal, P. T. Wong and W. K. Chui, Anticonvulsant activity of phenylmethyl-enehydantoins: A structure-activity relationship study, J. Med. Chem.47 (2004) 1527–1535; https://doi.org/10.1021/jm030450c10.1021/jm030450c14998338Search in Google Scholar

83. A. Karakurt, M. Ozalp, S. Isik, J. P. Stables and S. Dalkara, Synthesis, anticonvulsant and antimicrobial activities of some new 2-acetylnaphthalene derivatives, Bioorg. Med. Chem.18 (2010) 2902–2911; https://doi.org/10.1016/j.bmc.2010.03.01010.1016/j.bmc.2010.03.01020363141Search in Google Scholar

84. A. Husain, N. Siddiqui, M. Sarafroz, Y. Khatoon, M. Rasid and N. Ahmad, Synthesis, anticonvulsant and neurotoxicity screening of some novel 1,2,4-trisubstituted-1H-imidazole derivatives, Acta Pol. Pharm.68 (2011) 657–663.Search in Google Scholar

85. M. Amir, I. Ali and M. Z. Hassan, Imidazole incorporated semicarbazone derivatives as a new class of anticonvulsants: Design, synthesis and in vivo screening, Med. Chem.9 (2013) 571–580; https://doi.org/10.2174/157340641130904001110.2174/157340641130904001123651037Search in Google Scholar

86. S. Ulloora, R. Shabaraya, S. Aamir and A. V. Adhikari, New imidazo[1,2-a]pyridines carrying active pharmacophores: Synthesis and anticonvulsant studies, Bioorg. Med. Chem. Lett.23 (2013) 1502–1506; https://doi.org/10.1016/j.bmcl.2012.12.03510.1016/j.bmcl.2012.12.03523352511Search in Google Scholar

87. S. Ulloora, R. Shabaraya and A. V. Adhikari, Facile synthesis of new imidazo[1,2-a] pyridines carrying 1,2,3-triazoles via click chemistry and their antiepileptic studies, Bioorg. Med. Chem. Lett.23 (2013) 3368–3372; https://doi.org/10.1016/j.bmcl.2013.03.08610.1016/j.bmcl.2013.03.08623623419Search in Google Scholar

88. M. I. Attia, M. N. Aboul-Enein, A. A. El-Azzouny, Y. A. Maklad and H. A. Ghabbour, Anticonvulsant potential of certain new (2E)-2-[1-aryl-3-(1H-imidazol-1-yl)propylidene]-N-(aryl/H) hydrazinecarboxamides, Sci. World J. 2014 (2014) Article ID 357403 (9 pages); https://doi.org/10.1155/2014/35740310.1155/2014/357403391350924523636Search in Google Scholar

89. R. K. Gill, R. K. Rawal and J. Bariwal, Recent advances in the chemistry and biology of benzothiazoles, Arch. Pharm. (Weinheim) 348 (2015) 155–178; https://doi.org/10.1002/ardp.20140034010.1002/ardp.20140034025682746Search in Google Scholar

90. N. Siddiqui, A. Rana, S. A. Khan, M. A. Bhat and S. E. Haque, Synthesis of benzothiazole semicarbazones as novel anticonvulsants - the role of hydrophobic domain, Bioorg. Med. Chem. Lett.17 (2007) 4178–4182; https://doi.org/10.1016/j.bmcl.2007.05.04810.1016/j.bmcl.2007.05.04817572089Search in Google Scholar

91. A. Rana, N. Siddiqui, S. A. Khan, S. E. Haque and M. A. Bhat, N-{[(6-substituted-1,3-benzothiazole-2-yl)amino]carbonothioyl}-2/4-substituted benzamides: Synthesis and pharmacological evaluation, Eur. J. Med. Chem.43 (2008) 1114–1122; https://doi.org/10.1016/j.ejmech.2007.07.00810.1016/j.ejmech.2007.07.00817826870Search in Google Scholar

92. M. Z. Hassan, S. A. Khan and M. Amir, Design, synthesis and evaluation of N-(substituted benzothiazol-2-yl) amides as anticonvulsant and neuroprotective, Eur. J. Med. Chem.58 (2012) 206–213; https://doi.org/10.1016/j.ejmech.2012.10.00210.1016/j.ejmech.2012.10.00223124217Search in Google Scholar

93. N. Siddiqui, A. Rana, S. A. Khan, S. E. Haque, M. F. Arshad, S. Ahmed and W. Ahsan, Synthesis and preliminary screening of benzothiazol-2-yl thiadiazole derivatives for anticonvulsant activity, Acta Pharm. 59 (2009) 441–451; https://doi.org/10.2478/v10007-009-0031-x10.2478/v10007-009-0031-x19919933Search in Google Scholar

94. N. Siddiqui, S. N. Pandeya, S. A. Khan, J. Stables, A. Rana, M. Alam, M. F. Arshad and M. A. Bhat, Synthesis and anticonvulsant activity of sulfonamide derivatives-hydrophobic domain, Bioorg. Med. Chem. Lett.17 (2007) 255–259; https://doi.org/10.1016/j.bmcl.2006.09.05310.1016/j.bmcl.2006.09.05317046248Search in Google Scholar

95. A. A. Farag, S. N. Abd-Alrahman, G. F. Ahmed, R. M. Ammar, Y. A. Ammar and S. Y. Abbas, Synthesis of some azoles incorporating a sulfonamide moiety as anticonvulsant agents, Arch. Pharm. (Weinheim) 345 (2012) 703–712; https://doi.org/10.1002/ardp.20120001410.1002/ardp.20120001422696252Search in Google Scholar

96. N. Siddiqui, M. F. Arshad and S. A. Khan, Synthesis of some new coumarin incorporated thiazolyl semicarbazones as anticonvulsants, Acta Pol. Pharm. 66 (2009) 161–167.Search in Google Scholar

97. D. C. Liu, X. Q. Deng, S. B. Wang and Z. S. Quan, Synthesis and anticonvulsant activity evaluation of 7-alkoxy[1,2,4]triazolo[3,4-b]benzothiazol-3(2H)-ones, Arch. Pharm. (Weinheim) 347 (2014) 268–275; https://doi.org/10.1002/ardp.20130027710.1002/ardp.20130027724448887Search in Google Scholar

98. X. Q. Deng, M. X. Song, C. X. Wei, F. N. Li and Z. S. Quan, Synthesis and anticonvulsant activity of 7-alkoxy-triazolo-[3,4-b]benzo[d]thiazoles, Med. Chem.6 (2010) 313–320; https://doi.org/10.2174/15734061079335885510.2174/15734061079335885520977415Search in Google Scholar

99. N. Siddiqui, A. Rana, S. A. Khan, S. E. Haque, M. S. Alam, W. Ahsan and S. Ahmed, Synthesis of 8-substituted-4-(2/4-substituted phenyl)-2H-[1,3,5]triazino[2,1-b][1,3]benzothiazole-2-thiones and their anticonvulsant, anti-nociceptive, and toxicity evaluation in mice, J. Enzyme Inhib. Med. Chem.24 (2009) 1344–1350; https://doi.org/10.3109/1475636090288817610.3109/14756360902888176Search in Google Scholar

100. D. Liu, H. Zhang, C. Jin and Z. Quan, Synthesis and biological evaluation of novel benzothiazole derivatives as potential anticonvulsant agents, Molecules21 (2016) Article ID 164 (13 pages); https://doi.org/10.3390/molecules2103016410.3390/molecules21030164Search in Google Scholar

101. J. D. Conley and H. Kohn, Functionalized DL-amino acid derivatives. Potent new agents for the treatment of epilepsy, J. Med. Chem.30 (1987) 567–574; https://doi.org/10.1021/jm00386a02110.1021/jm00386a021Search in Google Scholar

102. H. Kohn, J. D. Conley and J. D. Leander, Marked stereospecificity in a new class of anticonvulsants, Brain Res.457 (1988) 371–375; https://doi.org/10.1016/0006-8993(88)90709-310.1016/0006-8993(88)90709-3Search in Google Scholar

103. H. Kohn, K. N. Sawhney, P. LeGall, J. D. Conley, D. W. Robertson and J. D. Leander, Preparation and anticonvulsant activity of a series of functionalized α-aromatic and α-heteroaromatic amino acids, J. Med. Chem.33 (1990) 919–926; https://doi.org/10.1021/jm00165a00610.1021/jm00165a0062308141Search in Google Scholar

104. H. Kohn, K. N. Sawhney, P. LeGall, D. W. Robertson and J. D. Leander, Preparation and anticonvulsant activity of a series of functionalized α-heteroatom-substituted amino acids, J. Med. Chem.34 (1991) 2444–2452; https://doi.org/10.1021/jm00112a02010.1021/jm00112a0201875341Search in Google Scholar

105. H. Kohn, K. N. Sawhney, P. Bardel, D. W. Robertson and J. D. Leander, Synthesis and anticonvulsant activities of α-heterocyclic α-acetamido-N-benzylacetamide derivatives, J. Med. Chem.36 (1993) 3350–3360; https://doi.org/10.1021/jm00074a01610.1021/jm00074a0168230125Search in Google Scholar

106. K. E. Andersen, C. Braestrup, F. C. Groenwald, A. S. Joergensen, E. B. Nielsen, U. Sonnewald, P. O. Soerensen, P. D. Suzdak and L. J. S. Knutsen, The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (Tiagabine) as an anticonvulsant drug candidate, J. Med. Chem.36 (1993) 1716–1725; https://doi.org/10.1021/jm00064a00510.1021/jm00064a0058510100Search in Google Scholar

107. J. Zheng, R. Wen, X. Luo, G. Lin, J. Zhang, L. Xu, L. Guo and H. Jiang, Design, synthesis, and biological evaluation of the N-diarylalkenyl-piperidinecarboxylic acid derivatives as GABA uptake inhibitors (I), Bioorg. Med. Chem. Lett.16 (2006) 225–227; https://doi.org/10.1016/j.bmcl.2005.09.00410.1016/j.bmcl.2005.09.00416246548Search in Google Scholar

108. N. Yadav, M. Malhotra, V. Monga, S. Sharma, J. Jain, Abdul Samad and A. Deep, Synthesis, characterization, and pharmacological evaluation of new GABA analogs as potent anticonvulsant agents, Med. Chem. Res.21 (2012) 2208–2216; https://doi.org/10.1007/s00044-011-9743-910.1007/s00044-011-9743-9Search in Google Scholar

109. R. Torregrosa, X. F. Yang, E. T. Dustrude, T. R. Cummins, R. Khanna and H. Kohn, Chimeric derivatives of functionalized amino acids and α-aminoamides: Compounds with anticonvulsant activity in seizure models and inhibitory actions on central, peripheral, and cardiac isoforms of voltage-gated sodium channels, Bioorg. Med. Chem.23 (2015) 3655–3666; https://doi.org/10.1016/j.bmc.2015.04.01410.1016/j.bmc.2015.04.014446151625922183Search in Google Scholar

110. C. O. Usifoh, D. M. Lambert, J. Wouters and G. K. E. Scriba, Synthesis and anticonvulsant activity of N,N-phthaloyl derivatives of central nervous system inhibitory amino acids, Arch. Pharm. (Weinheim) 334 (2001) 323–331; https://doi.org/10.1002/1521-4184(200110)334:10<323::AIDARDP323>3.0.CO;2-OSearch in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo